Cited by 74Tryptophan and brain disordersTreatment of Major DepressionStress Responses and Cortisol

Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression

Open access
Mehta, Divya, Raison, Charles L., Woolwine, Bobbi J., Haroon, Ebrahim, Binder, Elisabeth B., Miller, Andrew H., Felger, Jennifer C.·2013·Brain, Behavior, and Immunity

Abstract

The tumor necrosis factor (TNF) antagonist infliximab was recently found to reduce depressive symptoms in patients with increased baseline inflammation as reflected by a plasma C-reactive protein concentration >5 mg/L. To further explore predictors and targets of response to infliximab, differential gene expression was examined in peripheral blood mononuclear cells from infliximab responders (n=13) versus non-responders (n=14) compared to placebo at baseline and 6 h, 24 h, and 2 weeks after the first infliximab infusion. Treatment response was defined as 50% reduction in depressive symptoms at any point during the 12-week trial. One-hundred-forty-eight gene transcripts were significantly associated (1.2-fold, adjusted p≤0.01) with response to infliximab and were distinct from placebo responders. Transcripts predictive of infliximab response were associated with gluconeogenesis and cholesterol transport, and were enriched in a network regulated by hepatocyte nuclear factor (HNF)4-alpha, a transcription factor involved in gluconeogenesis and cholesterol and lipid homeostasis. Of the 148 transcripts differentially expressed at baseline, 48% were significantly regulated over time in infliximab responders, including genes related to gluconeogenesis and the HNF4-alpha network, indicating that these predictive genes were responsive to infliximab. Responders also demonstrated inhibition of genes related to apoptosis through TNF signaling at 6 h and 24 h after infusion. Transcripts down-regulated in responders 2 weeks after infliximab were related to innate immune signaling and nuclear factor-kappa B. Thus, baseline transcriptional signatures reflective of alterations in glucose and lipid metabolism predicted antidepressant response to infliximab, and infliximab response involved regulation of metabolic genes and inhibition of genes related to innate immune activation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2013.04.004

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., & Felger, J. C.
Affiliations
  • Max Planck Institute of Psychiatry (DE)
  • University of Arizona (US)
  • Emory University (US)
Corresponding author
Felger, Jennifer C.
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2013-07
Volume
31
Pages
205-215
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2054093295
Cited by
74
References
73
Citations by year
2026: 4 · 2025: 8 · 2024: 6 · 2022: 9 · 2021: 8 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 8 · 2015: 7 · 2014: 6 · 2013: 4
FWCI
2.82
Type
journal article
Language
en
Open access
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • National Institutes of Health (UL1TR000454, UL1TR002378)
  • National Institute of Mental Health (R21MH077172, R21 MH0771172, R03MH100273, R01MH108605, R01MH109637, R01MH087604)
  • National Cancer Institute (P30CA138292)
  • National Center for Research Resources (UL1RR025008, M01RR000039, M01-RR-0039)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
infliximab, treatment-resistant depression, tumor necrosis factor inhibitors, treatment response prediction, gene expression signatures, glucose metabolism, lipid metabolism, gluconeogenesis, cholesterol transport, peripheral blood mononuclear cells, inflammation, C-reactive protein, apoptosis, innate immune signaling, NF-κB, TNF signaling
MeSH terms
Infliximab, Adult, Antibodies, Monoclonal, Antidepressive Agents, Double-Blind Method, Female, Glucose, Humans, Male, Middle Aged, Tumor Necrosis Factor-alpha, Treatment Outcome, Gene Expression Profiling, Carbohydrate Metabolism, Lipid Metabolism, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review